Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2012 Apr 6.
Published in final edited form as: Tetrahedron Lett. 2011 Apr 6;52(14):1628–1630. doi: 10.1016/j.tetlet.2011.01.137

First total synthesis of (+)-Vedelianin, a potent antiproliferative agent

Joseph J Topczewski 1, David F Wiemer 1,*
PMCID: PMC3204860  NIHMSID: NIHMS272594  PMID: 22053119

Abstract

The total synthesis of (+)-vedelianin has been accomplished in 18 steps from vanillin. Preparation of a key intermediate in nonracemic form through a Shi epoxidation has allowed determination of the absolute stereochemistry of the natural product as the (2S, 3R, 4aR, 9aR)-isomer.


In 1992, the structure of vedelianin (1) was reported as part of an ethno-pharmacological investigation seeking compounds with hypotensive activity in extracts of Macaranga vedeliana.1 Although no such activity was noted for this compound, subsequent studies led to the first recognition of its potent antiproliferative activity,2 and a later investigation of a related plant led to isolation of vedelianin from M. alnifolia.3 Of the compounds isolated from M. alnifolia, vedelianin was found to be the most potent antiproliferative agent in one assay (IC50 = 130 nM vs. A2780 cells),3 and it also has been found to have a mean GI50 of 78 nM in the 60 cell line assay of the National Cancer Institute (NCI)2,4 and several individual cell lines have shown GI50 values below 1 nM. Based on vedelianin’s similarity to the natural schweinfurthins4 (e.g. schweinfurthin A, 2), its intriguing profile of activity in the NCI assays, and our interest in schweinfurthin synthesis,5 we undertook a total synthesis of vedelianin so that this potent member of the natural family would be accessible for further biological evaluation.

The total synthesis of vedelianin began with the known benzyl alcohol 4, which is available in four steps and ~50% overall yield from vanillin (3, Scheme 1).5a,5g Methylation of this intermediate via a Williamson ether synthesis then provided methyl ether 5 in excellent yield. Exposure of compound 5 to n-BuLi resulted in halogen–metal exchange, and when the resulting anion was quenched by slow addition of geranyl bromide the alkylated arene 6 was obtained.6 Epoxidation of the terminal olefin under Shi’s conditions7 proceeded to afford nonracemic epoxide 7 in high enantiomeric excess (average ee of 89% by HPLC analysis).5f Higher regio- and enantioselectivity could be obtained if the epoxidation was quenched prior to complete conversion, which resulted in quantities of recyclable starting material.

Scheme 1.

Scheme 1

A formal synthesis of schweinfurthin G.

In our past work it has been shown that an ortho MOM group can be used to terminate a cascade cyclization,5g although the liberated MOM group sometimes is found as part of a C-2 acetal. In this case, when epoxide 7 was treated with BF3·OEt2 the epoxide-initiated cascade cyclization proceeded smoothly to provide a roughly 2:1 mixture of hexahydroxanthenes 8 and 9, and each product was obtained as a single isomer. All observations support the conclusion that this cascade process proceeds with complete diastereoselectivity to afford the trans-fused products shown.5g Compounds 8 and 9 can be interconverted readily, either through protection of the A- ring hydroxyl group of compound 8 or hydrolysis of both MOM groups of compound 9 and selective protection of the C-ring phenol. This makes both compounds useful intermediates and increases material throughput for vedelianin. Alternatively, oxidation of the individual benzyl methyl ethers 8 and 9 upon exposure to DDQ8,5h provided aldehydes 10 and 11 respectively, and excellent yields were obtained in each case. The synthesis of compound 10 constitutes a formal synthesis of the closely related, although less potent, natural product schweinfurthin G.3, 5g

A vedelianin synthesis required elaboration of the hexahydroxanthene 8 to an A-ring diol (Scheme 2). Incorporation of a latent carbonyl group at the C-3 position was accomplished through a known three-step sequence first applied to prepare a related system.5h,5l Thus compound 8 was oxidized to the corresponding ketone by treatment with TPAP and NMNO, condensed with benzaldehyde in the presence of potassium hydroxide through a classic Claisen condensation, and reduced cleanly to the allylic alcohol 12 under Luche conditions.5l,9 In this series, protection of alcohol 12 was necessary to allow direct oxidative cleavage of the olefin with KMnO4, unmasking the latent C-3 ketone without oxidation at C-2. Therefore, alcohol 12 was treated with MOMCl and base to yield acetal 13. While use of this protecting group introduces an additional step to the synthetic sequence, this reaction proceeds in nearly quantitative yield when conducted at high concentrations and the C-2 MOM group can be removed as part of a late stage, global deprotection strategy. Treatment of the MOM acetal 13 with excess KMnO4 resulted in direct formation of ketone 14. This ketone could be reduced with complete selectivity to afford alcohol 15 as a single product.10 In this compound, the 1H NMR resonance for the C-3 hydrogen displayed coupling constants in good agreement with vedelianin (an apparent quartet with a J of ~3.2 Hz), and matches what would be expected for an equatorial hydrogen. Application of the DDQ-based oxidative deprotection then gave aldehyde 16 in quantitative yield.

Scheme 2.

Scheme 2

Total synthesis of vedelianin.

With aldehyde 16 in hand, the conclusion of vedelianin’s synthesis appeared to be straightforward, and the necessary HWE condensation first was attempted with phosphonate 18 under standard conditions5d,5k without protection of the C-3 hydroxyl group. However, when aldehyde 16 was treated with excess NaH and phosphonate 185e only trace amounts of the desired stillbene were isolated, and brief exploration of other conditions lead to only a margina improvement in yield. This was somewhat surprising given that similar HWE condensations in the 3-deoxy series routinely have been conducted without protection of the C-2 hydroxyl group. The sensitivity of compound 16 to strong base may result from a competing Grob fragmentation.11,12 While constraints imposed on this system by the planarity of the C-ring may make it difficult to achieve an ideal conformation for a concerted Grob fragmentation, the Bring oxygen does provide a good leaving group in the form of a phenoxide and a variety of non-concerted mechanisms are recognized.12 To minimize the possibility of a base-induced fragmentation, it was decided to protect the C-3 hydroxyl group. Treatment of aldehyde 16 with excess MOMCl and diisopropylethylamine resulted in quantitative formation of acetal 17. When the HWE condensation was attempted with the fully protected aldehyde 17 and KHMDS as base, olefination was facile and stilbene 19 was isolated in good yield. Stilbene 19 was treated with TsOH in methanol, resulting in hydrolysis of all five MOM acetal groups to afford vedelianin (1) along with a significant amount of partially hydrolyzed materials.13 The 1H and 13C NMR spectra of the synthetic vedelianin are in excellent agreement with those reported for the natural product.1 Furthermore, the specific rotation of the synthetic material matched both the sign and magnitude reported for vedelianin (lit1 +37, observed +35.3, for material of 90% ee by HPLC), which indicates that compound 1 has been prepared as the naturally occurring antipode. Based on the known absolute stereochemistry of aldehyde 10,5g ultimately generated by Shi epoxidation, the absolute stereochemistry of (+)-vedelianin now can be assigned as the (2S, 3R, 4aR, 9aR)-isomer.

In conclusion, we have accomplished the first total synthesis of (+)-vedelianin in 18 steps from vanillin. In addition, this work represents a more direct synthesis of the related compound schweinfurthin G. Finally, aldehydes 10, 11, 16, and 17 can serve as key intermediates in further efforts to delineate structure-activity relationships and in the synthesis of mechanistic probes to uncover vedelianin’s unique, and as yet unidentified, mechanism of antiproliferative activity.

Supplementary Material

01

Figure 1.

Figure 1

Natural hexahydroxanthenes.

Acknowledgments

We thank Dr. John A. Beutler (NCI–Frederick), Dr. Odile Thoisson, and Dr. Françoise Gueritte (ISCN CNRS, Gifsur-Yvette, France) for sharing data on the activity of (+)-vedelianin in the NCI 60 cell line screen, Dr. John G. Kodet for providing the initial vanillin derivative, and Dr. Nolan R. Mente for providing phosphonate 18. Financial support in the form of an ACS Division of Medicinal Chemistry predoctoral fellowship (to JJT), a Shriner Fellowship from the University of Iowa (to JJT), from the Roy J. Carver Charitable Trust, and the NIH (R41CA126020 via Terpenoid Therapeutics, Inc) is gratefully acknowledged.

Footnotes

Supplementary data

Experimental procedures and/or spectral data for compounds 1, 5-11, 13-17, and 19 are available. Supplementary data associated with this article can be found, in the online version, at doi:

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References and Notes

  • 1.Thoison O, Hnawia E, Gueritte-Voegelein F, Sevenet T. Phytochemistry. 1992;31:1439–1442. [Google Scholar]
  • 2.Vedelianin was tested in the 60 cell line assay of the National Cancer Institute in 2000 as NSC# 720065. Personal communication from Dr. John A. Beutler, NCI–Frederick.
  • 3.Yoder BJ, Cao S, Norris A, Miller JS, Ratovoson F, Razafitsalama J, Andriantsiferana R, Rasamison VE, Kingston DGI. J Nat Prod. 2007;70:342–346. doi: 10.1021/np060484y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.a) Beutler JA, Shoemaker RH, Johnson T, Boyd MR. J Nat Prod. 1998;61:1509–1512. doi: 10.1021/np980208m. [DOI] [PubMed] [Google Scholar]; b) Beutler JA, Jato J, Cragg GM, Boyd MR. Nat Prod Lett. 2000;14:399–404. [Google Scholar]; c) Beutler JA, Jato JlCG, Wiemer DF, Neighbors JD, Salnikova MS, Hollingshead M, Scudiero DA, McCloud TG. The Schweinfurthins: Issues in Development of a Plant-Derived Anticancer Lead. In: Bogers RJ, editor. Medicinal and Aromatic Plants. Springer; 2006. pp. 301–309. [Google Scholar]
  • 5.a) Treadwell EM, Cermak SC, Wiemer DF. J Org Chem. 1999;64:8718–8723. [Google Scholar]; b) Neighbors JD, Beutler JA, Wiemer DF. J Org Chem. 2005;70:925–931. doi: 10.1021/jo048444r. [DOI] [PubMed] [Google Scholar]; c) Wiemer DF, Neighbors JD, Beutler JA. In PCT Int. Appl. Preparation of Schweinfurthin analogues. 2005092878 A2 20051006 CAN 143:347317 AN 2005:1075787 CODEN: PIXXD2 WO. 2005; d) Neighbors JD, Salnikova MS, Beutler JA, Wiemer DF. Biorg Med Chem. 2006;14:1771–1784. doi: 10.1016/j.bmc.2005.10.025. [DOI] [PubMed] [Google Scholar]; e) Mente NR, Wiemer AJ, Neighbors JD, Beutler JA, Hohl RJ, Wiemer DF. Biorg Med Chem Lett. 2007;17:911–915. doi: 10.1016/j.bmcl.2006.11.096. [DOI] [PubMed] [Google Scholar]; f) Neighbors JD, Mente NR, Boss KD, Zehnder DW, II, Wiemer DF. Tetrahedron Lett. 2008;49:516–519. [Google Scholar]; g) Mente NR, Neighbors JD, Wiemer DF. J Org Chem. 2008;73:7963–7970. doi: 10.1021/jo800951q. [DOI] [PMC free article] [PubMed] [Google Scholar]; h) Topczewski JJ, Neighbors JD, Wiemer DF. J Org Chem. 2009;74:6965–6972. doi: 10.1021/jo901161m. [DOI] [PubMed] [Google Scholar]; i) Neighbors JD, Topczewski JJ, Swenson DC, Wiemer DF. Tetrahedron Lett. 2009;50:3881–3884. [Google Scholar]; j) Kuder CH, Neighbors JD, Hohl RJ, Wiemer DF. Bioorg Med Chem. 2009;17:4718–4723. doi: 10.1016/j.bmc.2009.04.071. [DOI] [PMC free article] [PubMed] [Google Scholar]; k) Ulrich NC, Kodet JG, Mente NR, Kuder CH, Beutler JA, Hohl RJ, Wiemer DF. Bioorg Med Chem. 2010;18:1676–1683. doi: 10.1016/j.bmc.2009.12.063. [DOI] [PMC free article] [PubMed] [Google Scholar]; l) Topczewski JJ, Kodet JG, Wiemer DF. J Org Chem. 2011:76. doi: 10.1021/jo1022102. in press. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.While this reaction could be conducted by addition of n-BuLi to the aryl halide, more reproducible yields were obtained through addition of the aryl halide to a solution of the n-BuLi.
  • 7.Wang Z, Shi Y. J Org Chem. 1998;63:3099–3104. doi: 10.1021/jo980604+.Shi Y. Acc Chem Res. 2004;37:488–496. doi: 10.1021/ar030063x.The absolute stereochemistry of epoxide 7 was assigned as R based on the literature precedents above, and confirmed by direct comparison of compound 10 with material prepared by other means.5g Single crystal diffraction analyses of both trans-fused5h and cis-fused5i hexahydroxanthenes have confirmed that the stereochemistry of the epoxide controls the stereochemistry of the ring fusion in the tricyclic product.
  • 8.Cook SP, Danishefsky SJ. Org Lett. 2006;8:5693–5695. doi: 10.1021/ol062067i. [DOI] [PubMed] [Google Scholar]; b) Cook SP, Gaul C, Danishefsky SJ. Tetrahedron Lett. 2005;46:843–847. [Google Scholar]
  • 9.Luche JL, Gemal ALJ. Chem Soc, Chem Commun. 1978:976–977. [Google Scholar]
  • 10.Wen X, Xia J, Cheng K, Zhang L, Zhang P, Liu J, Zhang L, Ni P, Sun H. Biorg Med Chem Lett. 2007;17:5777–5782. doi: 10.1016/j.bmcl.2007.08.057. [DOI] [PubMed] [Google Scholar]
  • 11.a) Eschenmoser A, Frey A. Helv Chim Acta. 1952;35:1660–1666. [Google Scholar]; b) Grob CA, Schiess PW. Angew Chem, Int Ed Engl. 1967;6:1–15. [Google Scholar]; c) Grob CA. Angew Chem, Int Ed Engl. 1969;8:535–546. [Google Scholar]; d) Kato M, Tooyama Y, Yoshikoshi A. Chemistry Lett. 1989:61–64. [Google Scholar]
  • 12.a) Prantz K, Mulzer J. Chem Rev. 2010;110:3741–3766. doi: 10.1021/cr900386h. [DOI] [PubMed] [Google Scholar]; b) Green JC, Pettus TRR. J Am Chem Soc. 2011 doi: 10.1021/ja109925g. ASAP, dx.doi.org/10.1021/ja109925g. [DOI] [PubMed] [Google Scholar]
  • 13.Hydrolysis of the C-2 and C-3 MOM groups proceeds significantly more slowly then hydrolysis of the phenolic MOM groups. Based on TLC analysis of the reaction mixture, we hypothesize that the partially hydrolyzed material is a mixture of vedelianin derivatives that still carry MOM groups at C-2 and/or C-3.

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

01

RESOURCES